Business Context and Reporting Period
Company: DATA I/O CORPORATION
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2004
Business Overview: Data I/O designs and manufactures semiconductor programming equipment, including automated and non-automated systems. The company operates globally with significant international exposure (79.7% of Q1 2004 sales). Management is focusing on strategic growth markets, specifically new programming technology and automated systems for manufacturing environments, while managing costs in a weak economic environment.
Key Financial Metrics
| Metric (in thousands) | Q1 2004 | Q1 2003 |
|---|---|---|
| Net Sales | $6,834 | $6,155 |
| Gross Margin | $3,713 | $3,437 |
| Gross Margin % | 54.3% | 55.8% |
| Operating Income | $337 | $375 |
| Net Income | $296 | $317 |
| Earnings Per Share (Basic & Diluted) | $0.04 | $0.04 |
| Cash and Cash Equivalents (End of Period) | $3,706 | $5,645 |
| Working Capital | $10,968 | $11,032 |
| Total Debt | $0 | $0 |
Cash Flow Summary (Q1 2004):
- Net cash used in operating activities: $(132) thousand
- Net cash used in investing activities: $(569) thousand
- Net cash provided by financing activities: $89 thousand
- Net decrease in cash: $(612) thousand
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 11.0% year-over-year, driven primarily by an 18.0% increase in automated programming systems sales and a 25.4% increase in international sales. Conversely, U.S. sales declined 23.4%.
- Margin Compression: While gross margin dollars increased, the gross margin percentage decreased from 55.8% to 54.3%. This was attributed to unfavorable labor and overhead variances associated with a $555,000 reduction in inventory, partially offset by favorable currency translation effects.
- Operating Expenses: Total operating expenses increased to $3.376 million from $3.062 million. SG&A expenses rose $244,000 due to strategic investments in Asia, hiring, and higher commission costs. R&D spending increased slightly to $1.204 million.
- Backlog: Order backlog decreased from $1.5 million to $820,000 during the quarter.
- Foreign Currency: Foreign currency exchange loss was $14,000 in Q1 2004, a significant improvement from a $76,000 loss in Q1 2003.
Guidance, Outlook, and Risks
Management Commentary & Outlook:
- Management expects demand for capacity to improve in 2004, driven by forecasted increased unit sales in the semiconductor industry.
- The company is expanding operations in China (Shanghai) and Brazil to support geographic growth.
- Capital expenditures for the remainder of 2004 are estimated at approximately $500,000, excluding strategic purposes.
- Management forecasts gross margin percentages to remain at approximately the current quarter's level.
Risks and Contingencies:
- Market Risk: Significant exposure to foreign currency fluctuations (Euro, Canadian Dollar, Chinese Yuan). The company uses forward contracts to hedge Euro exposure.
- Inventory Risk: Rapid technological change could lead to inventory obsolescence if demand forecasts are inaccurate.
- Concentration Risk: Dependence on a limited number of suppliers for key components and reliance on third-party distributors.
- Legal/Tax: The company maintains a full valuation allowance of $9.783 million against deferred tax assets due to uncertainty regarding realization of net operating loss carryforwards.
Investor Verification Checklist
- International Sales Mix: Verify the sustainability of the 79.7% international sales mix and the impact of currency fluctuations on future margins.
- Inventory Levels: Monitor inventory reduction trends ($4.053 million) against sales volume to assess obsolescence risk.
- Backlog Trends: Confirm if the reduction in backlog to $820,000 is a temporary fluctuation or a leading indicator of demand softness.
- Capital Expenditures: Track actual spending against the $500,000 estimate for the remainder of 2004, particularly regarding the new Shanghai and Brazil operations.
- Debt-Free Status: Confirm the company maintains its zero-debt status while funding expansion and R&D from operating cash flows.